CMC Stock Recent News

Commercial Metals (CMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

UK-listed forex and contracts for difference (CFD) companies are doing well this year as monthly volumes bounce back and their cost-cutting measures work. Plus500 (PLUS) share price has risen in the last six consecutive months and in 9 of the last 10 months.

VANCOUVER, BC / ACCESSWIRE / August 27, 2024 / CMC Metals Ltd. (TSX-V:CMB)(Frankfurt:ZM5P)(CMCXF:OTCQB) ("CMC" or the "Company") CMC is very pleased to announce that on August 22, 2024, North Bay Resources (the "Company" or "North Bay") (OTC: NBRI) announced highly positive results from a preliminary metallurgical/brevity recovery testing of run of mine ore from the Mt.

VANCOUVER, BC / ACCESSWIRE / August 15, 2024 / CMC Metals Ltd. (TSX-V:CMB)(Frankfurt:ZM5P)(OTCQB:CMCXF) ("CMC" or the "Company") CMC Metals Ltd.

Barbara R. Smith to Retire as Executive Chairman Robert S. Wetherbee Appointed Chairman of the Board of Directors Vicki Avril-Groves to Retire from the Board of Directors Tandra Perkins Appointed to the Board of Directors IRVING, Texas , Aug. 2, 2024 /PRNewswire/ -- Commercial Metals Company (NYSE: CMC) ("CMC" or the "Company") today announced that Barbara R.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

HUNTSVILLE, AL, July 18, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, today announced the appointment of Dr. Srini Tenjarla as the new Senior Vice President of CMC (Chemistry, Manufacturing, and Controls) and Formulation. Dr. Tenjarla brings over 20 years of extensive experience in drug development to Serina.

Nose-to-Brain Drug Delivery Shows Promising Patient Safety and Therapeutic Benefit The Device and CMC Development Master Plan is designed to support IND-enabling studies SARASOTA, FL, July 18, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. Resyca is a joint venture between Bespak Group and Medspray Pharma BV which manufactures the formulation-specific microchip-based spray system chosen by Silo for its lead candidate SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD).

Commercial Metals (CMC) gains from strong demand in North America for each of its primary product lines. However, market uncertainties in Europe remain a concern for the company.

VANCOUVER, BC / ACCESSWIRE / June 27, 2024 / CMC Metals Ltd. (TSXV:CMB)(Frankfurt:ZM5P)(OTCQB:CMCXF) ("CMC" or the "Company") is pleased to announce that the Company has completed the final payment on the Blue Heaven Property with the optionor Strategic Metals Ltd.